Key Takeaways
- Raymond James launched coverage on RKLB with “Outperform” status and set an $80 price objective, suggesting potential gains exceeding 25%.
- The company’s contract backlog reached $2.36 billion, representing a 137% annual increase, while quarterly sales climbed 62% to $234.1 million.
- Major institutional players like BlackRock and Bank of America established significant new positions during Q2; institutional ownership now stands at 71.78%.
- A notable concern is insider stock sales exceeding $312 million over the previous three months.
- Wall Street’s consensus view is “Moderate Buy” with an average price projection of $107.32.
Rocket Lab (RKLB) currently trades at prices representing more than a 55% discount from its peak this year, yet analyst sentiment is shifting increasingly positive.
On September 11, Raymond James analyst Brian Gesuale launched coverage with an “Outperform” designation and established an $80 price objective. This target represents potential appreciation exceeding 25% from the stock’s trading level when the analysis was published.
Gesuale’s primary thesis centers on Rocket Lab’s evolution beyond being merely a launch provider. The company has developed comprehensive end-to-end mission capabilities, delivering components, software solutions, and satellite platforms for civil, commercial, and national security applications.
This bifurcated revenue model, merging launch operations with space systems, generates recurring income streams that pure launch competitors cannot replicate.
The analyst contends that the market is failing to properly value RKLB’s future earnings capacity as defense and scientific program contracts expand.
Unprecedented Backlog Growth and Revenue Momentum
Rocket Lab concluded its latest reporting period with a contract backlog totaling $2.36 billion, marking a 137% increase versus the comparable year-ago quarter. This level of forward revenue visibility is exceptional for companies at this development stage.
The company posted quarterly revenue of $234.1 million, representing 62% year-over-year growth. Rocket Lab also maintains a cash position exceeding $2 billion.
Raymond James highlighted these metrics as proof that market valuations haven’t fully incorporated the company’s long-term profitability trajectory.
The company recently achieved its 95th Electron mission, successfully placing an Earth-observation satellite into a 500-kilometer orbit. This marked the firm’s 16th launch in the current year, with an additional commercial mission scheduled before September concludes.
Institutional Accumulation Contrasts With Insider Exits
Significant institutional capital has flowed into RKLB recently. Virginia Retirement Systems purchased 10,539 shares during Q2, valued at approximately $1.07 million. BlackRock initiated a new position worth around $4.1 billion. Bank of America established a fresh stake totaling roughly $437 million. Institutional shareholders currently control 71.78% of outstanding shares.
Conversely, company insiders have been reducing holdings. During the past three months, insider dispositions exceeded $312 million in value, with 97 insider transactions recorded on the sell side and none on the buy side. CEO Peter Beck participated in these sales.
While some dispositions occurred through predetermined Rule 10b5-1 trading arrangements and were linked to tax liabilities from vested equity compensation, the transaction volume remains substantial.
Raymond James isn’t the only firm expressing confidence. Berenberg Bank initiated coverage on September 2 with a “Buy” recommendation and an $83 price objective. Citizens JMP maintains a $130 target. The analyst community’s aggregate view is “Moderate Buy” with a mean price target of $107.32.
Weiss Ratings represents an outlier with a “Sell” rating. Piper Sandler holds a “Neutral” stance with an $83 target.
Current analyst coverage includes four “Strong Buy” recommendations, fourteen “Buy” ratings, five “Hold” opinions, and one “Sell” rating.





